As shown in (Figure 2A), the weighted multivariable-adjusted mean ALT levels were significantly lower in HEPA active participants with NAFLD than in minimally active and inactive participants with NAFLD (34.0 ± 1.2 in HEPA active; 36.7 ± 1.3 in minimally active; 37.5 ± 1.2 in inactive participants; p = 0.018). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.